10 "

: Saphris 10 Mg. ?  »
|
-

PER OS

Tablets Sublingual

Schizophrenia SAPHRIS is indicated for the treatment of schizophrenia in adults. The efficacy of SAPHRIS was established in two 6-week trials and one maintenance trial in adults Bipolar Disorder Monotherapy: SAPHRIS is indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder. Efficacy was established in two 3-week monotherapy trials in adults Adjunctive Therapy: SAPHRIS is indicated as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder. Efficacy was established in one 3-week adjunctive trial in adults.

146 05 33229 00

Organon (ireland) Ltd, Ireland

05/2011 - 04/2016

.
, .
.
/
Asenapine as maleate 10 MG
Blister aluminium 20 x TABLETS 36
Blister aluminium 100 x TABLETS 36
Blister aluminium 60 x TABLETS 36

*

*

 

.

 
" !
 

? !
 »
101
( ) , -